Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beyond Rebates: PhRMA Wants HHS To ‘De-Link’ Supply Chain Compensation From List Price

Executive Summary

Focus should not be limited to rebates in Medicare Part D, manufacturers advise in comments on HHS drug pricing blueprint. Pharmacy benefit managers raise anti-trust issues with shift to upfront discounts.

Advertisement

Related Content

Express Scripts Pushing Manufacturers To Lower List Prices By Offering Cheaper Brand Alternatives
Part D Point-Of-Sale Rebates Losing Appeal? CBO Confirms Big Cost To Medicare
Trump Drug Pricing Plan Includes Part D Surprises, Challenges PBM Business Model
A World Without Rebates: Is FDA’s Gottlieb Offering New Vision?
Point-Of-Sale Rebates In Part D Could Save Seniors $20bn, PhRMA Argues

Topics

Advertisement
UsernamePublicRestriction

Register

SC123424

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel